HomeCompareNURPF vs FCPT

NURPF vs FCPT: Dividend Comparison 2026

NURPF yields 24.33% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NURPF wins by $45.8K in total portfolio value
10 years
NURPF
NURPF
● Live price
24.33%
Share price
$8.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$94.9K
Annual income
$10,445.94
Full NURPF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — NURPF vs FCPT

📍 NURPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNURPFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NURPF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NURPF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NURPF
Annual income on $10K today (after 15% tax)
$2,068.13/yr
After 10yr DRIP, annual income (after tax)
$8,879.05/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, NURPF beats the other by $3,970.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NURPF + FCPT for your $10,000?

NURPF: 50%FCPT: 50%
100% FCPT50/50100% NURPF
Portfolio after 10yr
$72.0K
Annual income
$8,110.61/yr
Blended yield
11.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

NURPF
No analyst data
Altman Z
210.3
Piotroski
6/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NURPF buys
0
FCPT buys
0
No recent congressional trades found for NURPF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNURPFFCPT
Forward yield24.33%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$94.9K$49.1K
Annual income after 10y$10,445.94$5,775.28
Total dividends collected$59.3K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NURPF vs FCPT ($10,000, DRIP)

YearNURPF PortfolioNURPF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$13,133$2,433.09$11,401$700.92+$1.7KNURPF
2$17,039$2,986.35$13,064$864.84+$4.0KNURPF
3$21,852$3,621.00$15,051$1,072.48+$6.8KNURPF
4$27,722$4,340.18$17,442$1,337.22+$10.3KNURPF
5$34,809$5,145.80$20,340$1,677.08+$14.5KNURPF
6$43,284$6,038.47$23,880$2,116.57+$19.4KNURPF
7$53,331$7,017.47$28,241$2,689.36+$25.1KNURPF
8$65,145$8,080.76$33,660$3,442.07+$31.5KNURPF
9$78,930$9,225.06$40,456$4,439.95+$38.5KNURPF
10$94,901$10,445.94$49,063$5,775.28+$45.8KNURPF

NURPF vs FCPT: Complete Analysis 2026

NURPFStock

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as has completed Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase I clinical trial for the treatment of Phelan-McDermid, Angelman, Pitt Hopkins, and Prader-Will syndromes. In addition, it provides development services; and holds loan funded shares. The company was incorporated in 2001 and is based in Camberwell, Australia.

Full NURPF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this NURPF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NURPF vs SCHDNURPF vs JEPINURPF vs ONURPF vs KONURPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.